GALESBURG COTTAGE HOSPITAL
1. Target Overview & Investment Thesis
GALESBURG COTTAGE HOSPITAL is a 96-bed suburban community hospital in KNOX, IL with $86.7M in net patient revenue and a 82.4% operating margin. The hospital serves a payer mix of 54.2% Medicare, 3.8% Medicaid, and 42.0% commercial.
Thesis: Turnaround. Our ML models identify $6.4M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 82.4% to 89.8% (+736bps).
| Net Revenue HCRIS | $86.7M |
| Current EBITDA COMPUTED | $71.5M |
| Operating Margin COMPUTED | 82.4% |
| Occupancy HCRIS | 9.2% |
| Revenue / Bed COMPUTED | $903K |
| Net-to-Gross HCRIS | 33.1% |
| Distress Probability ML | 59.3% |
2. Market Context & Competitive Position
IL has 208 Medicare-certified hospitals with a median operating margin of -5.3%. The target's margin of 82.4% places it above the state median. Among 79 size-comparable peers (48-192 beds), the median margin is -8.3%. The target performs in line with or above peers.
3. RCM Performance Analysis — Comparable Hospitals
Comps selected by bed count (48-192), prioritizing same-state peers. 79 hospitals in the comp set.
| Hospital | State | Beds | Revenue | Margin |
|---|---|---|---|---|
| GALESBURG COTTAGE HOSPITAL (Target) | IL | 96 | $86.7M | 82.4% |
| MIDWESTERN REGIONAL MEDICAL CE | IL | 73 | $1.38B | 80.5% |
| NORTHWESTERN LAKE FOREST HOSPI | IL | 124 | $494.3M | -13.8% |
| SARAH BUSH LINCOLN HEALTH CENT | IL | 100 | $448.6M | -18.1% |
| DELNOR-COMMUNITY HOSPITAL | IL | 149 | $441.4M | 6.4% |
| GOOD SHEPHERD HOSPITAL | IL | 176 | $375.2M | 20.0% |
| SWEDISH COVENANT HEALTH | IL | 173 | $363.5M | -3.8% |
| MEMORIAL HOSPITAL OF CARBONDAL | IL | 175 | $357.2M | 14.6% |
| KISHWAUKEE COMMUNITY HOSPITAL | IL | 98 | $355.3M | 25.5% |
4. Predicted Improvement Opportunities
Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $6.4M (736bps margin improvement).
| Lever | Current | Target | EBITDA Impact | Margin | Ramp |
|---|---|---|---|---|---|
| Net Collection Rate | 93.5% | 97.0% | $1.8M | +210bp | 18mo |
| Cost to Collect | 4.5% | 2.5% | $1.7M | +200bp | 12mo |
| Denial Rate Reduction | 12.0% | 6.5% | $1.7M | +198bp | 12mo |
| A/R Days Reduction | 5200.0% | 3800.0% | $1.1M | +122bp | 9mo |
| Clean Claim Rate | 88.0% | 96.0% | $55K | +6bp | 6mo |
5. EBITDA Bridge
| Current EBITDA | $71.5M |
| + RCM Uplift | +$6.4M |
| Pro Forma EBITDA | $77.9M |
| Current Margin | 82.4% |
| Pro Forma Margin | 89.8% |
| WC Released (1x) | $3.3M |
6. Returns Analysis — Scenario Matrix
5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.
| Scenario | Entry | Exit | Equity In | Equity Out | MOIC | IRR |
|---|---|---|---|---|---|---|
| Base Case | 10.0x | 10.0x | $110.0M | $535.4M | 4.87x | 37.2% |
| Base (11x exit) | 10.0x | 11.0x | $110.0M | $624.6M | 5.68x | 41.5% |
| Bull Case | 9.0x | 11.0x | $99.0M | $681.4M | 6.88x | 47.1% |
| Bull (12x exit) | 9.0x | 12.0x | $99.0M | $772.6M | 7.81x | 50.8% |
| Bear Case | 11.0x | 10.0x | $121.0M | $467.7M | 3.87x | 31.1% |
| Bear (11x exit) | 11.0x | 11.0x | $121.0M | $553.8M | 4.58x | 35.6% |
7. Key Risks & Mitigants
| Severity | Risk Factor | Mitigant |
|---|---|---|
| Medium | Low occupancy | At 9.2%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case |
| High | Elevated distress probability | Model estimates 59.3% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk |
8. Data Sources & Methodology Appendix
Data Sources
- CMS HCRIS Cost Reports (Medicare-certified hospitals)
- CMS Medicare Utilization (DRG-level volumes)
- CMS Chronic Conditions (county-level disease prevalence)
- HCRIS multi-year trend data (financial time series)
Comparable Selection
- 79 hospitals with 48-192 beds
- Same-state prioritization (n=80)
- Comp margins: P25=-22.1% / P50=-8.3% / P75=3.7%
Bridge Methodology
- Targets: P75 of comparable peers (60% gap closure)
- Denial: avoidable share = 35% of delta × NPR
- AR: bad debt coefficient = $0.65 per day per $1K NPR
- NCR: 60% coefficient on collection rate improvement
- CDI: 0.75% of Medicare revenue per 0.01 CMI point
Returns Assumptions
- Leverage: 5.5x entry (84.6% debt / 15.4% equity)
- Organic growth: 3% annual EBITDA growth
- Debt paydown: 10% of principal per year
- Hold period: 5 years
Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.